It is known that ginger oleoresin contains various active components and possesses bioactivities. In this study, ginger oleoresin from Chinese ginger (Zingiber officinale var. roscoe) was extracted using a CO₂ supercritical fluid extraction method with a 0.52% yield (g/g), based on dry weights. Zingiberene with a content of 51.6 mg/g was the main volatile in the ginger oleoresin. In total, 17 phenolic compounds were identified, and their contents were calculated as 587.54 mg/g. Among them, a new gingertriol was detected in the Z. officinale. Antioxidant activity tests showed that the ginger oleoresin and six gingerols exhibited strong scavenging free radical activities, and the zingerone exhibited the strongest antioxidant activity, with IC₅₀ values of 11.3 µg/mL for the 2, 2′-diphenyl-1-picrylhydrazyl radical and 19.0 µg/mL for the 2, 2′-amino-di (2-ethyl-benzothiazoline sulphonic acid-6) ammonium salt radical cation, comparable to vitamin C. Ginger oleoresin inhibits HGC-27 human gastric cancer cell proliferation at a rate of 4.05~41.69% and induces cell apoptosis at a rate of 10.4~20.9%. The Western blot result demonstrated that the AKT signaling pathway has the potential mechanism of ginger oleoresin acting on HGC-27 cells. The anticancer potential of the gingerol standards on HGC-27 cells followed the order of 8-gingerol > 6-gingerol > 10-gingerol > zingerone. The different antioxidant and anticancer potentials of the ginger phenolic compounds could be attributed to the presence of hydroxyl groups in the unbranched 1-alkyl chain and the length of carbon side chain. Consequently, ginger oleoresin shows substantial antioxidant and anticancer therapeutic potential and can be used for novel food–drug development.

Zheng Chen, Enquan Lin, Xia Lin, Lianlian Liu, Wangyu Li, Junjie Feng, Bo Liu, Xuefang Zheng, and Meichun Chen. J. Microbiol. Biotechnol. 2025;35:1-12. https://doi.org/10.4014/jmb.2501.01033

In the post-antibiotic era, the Bacillus-based direct-fed beneficial microorganisms are emerging as a cornerstone for sustainable animal farming. This study aimed to screen and evaluate Bacillus strains with probiotic potential for use as feed additives. A total of 394 Bacillus strains were initially screened based on their extracellular enzyme production (cellulase, protease, and amylase) and antibacterial activities against Escherichia coli, Staphylococcus aureus, and Salmonella enterica. Two strains, Bacillus velezensis FJAT-10508 and FJAT-13563, were selected and subsequently subjected to in vitro probiotic characterization, safety assessment, and whole-genome analysis. The results demonstrated that both strains exhibited α-hemolysis, acceptable antibiotic susceptibility profiles, absence of invasion and cytotoxicity effect on the Caco-2 cells, and no mobile virulence or antibiotic resistance genes, indicating their safety as probiotic candidates. High endospore-forming efficiencies (72.4–90.8%), strong auto-aggregation (74–85%) and co-aggregation abilities (52–82%) were observed. In addition, both strains showed considerable tolerance to simulated gastrointestinal conditions, with vegetative cell and endospore survival rates of 28.33–38.33% and 85–89.67% at pH 2.0, and 38.33–43.33% and 90.33–96.33% in 0.3% bile salts, respectively. Overall, B. velezensis FJAT-10508 and FJAT-13563 demonstrated robust in vitro probiotic properties, supporting their potential application as reliable Bacillus-based feed additives.

The aim of this study was to acquire endospore-former(s) for aquatic animal feed based on the probiotic potential in vitro, including the anti-pathogen spectrum, gastrointestinal fluid tolerance, antioxidant activity, enzyme-producing ability, and basic safety assessment. The strain Bacillus velezensis FJAT-57093 was found to exhibit the strongest antibacterial ability against Aeromonas hydrophila in the agar well diffusion inhibition assays from 111 Bacillus-like strains. Moreover, the results showed that the compounds of the strain FJAT-57093 enriched by acid precipitation might be the main antibacterial metabolites. The strain FJAT-57093 also exhibited antibacterial effects against the aquatic pathogens Photobacterium damselae, Edwardsiella tarda, Vibrio parahaemolyticus, and Vibrio vulnificus. The safety assessment revealed that the strain FJAT-57093 was non-hemolytic and susceptible to ten antibiotics. The putative virulence and antibiotic resistance genes predicted were predominantly intrinsic to the FJAT-57093 genome. Furthermore, the strain FJAT-57093 demonstrated a tolerance of acid and bile salt under the simulated gastrointestinal tract conditions, extracellular enzyme-producing abilities, as well as an auto-aggregation rate of 45.88% at 24 h and co-aggregation rates with the aforementioned five aquatic pathogens, ranging from 14.87% to 58.55%. Additionally, its extracellular metabolites displayed strong antioxidant activities, with ABTS⁺ and DPPH radical scavenging rates of up to 99.82% and 42.74%, respectively. In summary, the strain B. velezensis FJAT-57093 was found to possess strong antibacterial activities against multiple aquatic pathogens and desirable in vitro probiotic properties.

Pseudostellaria heterophylla is one of the Chinese herbal medicines with high medicinal and economic values. From 2019 to 2021, postharvest green mold disease was observed with an incidence of 2~5%...

Bacterial wilt, caused by Ralstonia solanacearum, poses a significant threat to global tomato production, underscoring the need for sustainable management strategies. In this study, we characterized a novel lipopeptide from Bacillus pumilus strain LP-823 and evaluated its efficacy against tomato bacterial wilt. Structural analysis using LC-QTOF MS/MS identified the lipopeptides as surfactin variants with fatty acid chains ranging from C₁₄ to C₁₉, including C₁₇-C₁₉ homologues not previously reported in this species. In pot experiments, treatment with LP-823 lipopeptides significantly suppressed disease development, delaying symptom onset by four days and reducing final disease incidence and disease index by 29.63% and 36.19%, respectively, at 20 days post-inoculation. The lipopeptides exhibited no direct antibacterial activity in vitro. Instead, they triggered plant-mediated defense responses, as evidenced by marked increases in phenylalanine ammonia-lyase (PAL) and polyphenol oxidase (PPO) activities, which peaked at 36 h post-treatment with 5.7-fold and 6.8-fold increases, respectively. Integrated transcriptomic and metabolomic analyses revealed that lipopeptide treatment orchestrates a multifaceted defense network, including modulation of ROS homeostasis (downregulation of AOX1a and CAT2), reprogramming of ABA signaling (upregulation of ABI2, downregulation of ZEP), suppression of aquaporin (PIP2-1) expression, and redirection of phenylpropanoid metabolism. These coordinated responses collectively explain the observed disease suppression and enhanced defense enzyme activities. Overall, our results establish the LP-823 lipopeptide as a potent elicitor of induced systemic resistance with considerable potential for the sustainable management of bacterial wilt in tomato.